Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Calverley

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Clinics in Chest Medicine|February 11, 2014
Current drug treatment, chronic and acutePeter Calverley
MMW Fortschritte Der Medizin|July 18, 2003
[New studies refute steroid opponents. COPD--after all a case for corticosteroids?]Peter Calverley
American Journal of Respiratory and Critical Care Medicine|August 8, 2020
Angels Dancing on the Tip of a Needle: Interpreting Clinical Trials in Chronic Obstructive Pulmonary DiseasePeter Calverley
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
New Pharmacotherapeutic Approaches for Chronic Obstructive Pulmonary DiseasePeter Calverley, Ben Vlies
Respirology (Carlton, Vic.)|November 28, 2015
A rational approach to single, dual and triple therapy in COPDPeter Calverley, Ben Vlies
Lancet (London, England)|June 17, 2008
A PEACE-ful solution to COPD exacerbations?Paul Albert, Peter Calverley
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Plugging the gap-understanding mucus plugs in COPDPeter Calverley, Jadwiga A Wedzicha
Drug Safety|December 16, 2020
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A ReviewPeter Calverley, Paola Rogliani, Alberto Papi
British Journal of Clinical Pharmacology|May 21, 2016
Tiotropium safety in 'real-world' populations: Response to Schmiedl, et al. in the British Journal of Clinical PharmacologyRobert Wise, Antonio Anzueto, Ronald Dahl, et al.
COPD|August 31, 2007
Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodologyTerence Seemungal, Robert Stockley, Peter Calverley, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Clinics in Chest Medicine|February 11, 2014
Current drug treatment, chronic and acutePeter Calverley
MMW Fortschritte Der Medizin|July 18, 2003
[New studies refute steroid opponents. COPD--after all a case for corticosteroids?]Peter Calverley
American Journal of Respiratory and Critical Care Medicine|August 8, 2020
Angels Dancing on the Tip of a Needle: Interpreting Clinical Trials in Chronic Obstructive Pulmonary DiseasePeter Calverley
Seminars in Respiratory and Critical Care Medicine|August 5, 2015
New Pharmacotherapeutic Approaches for Chronic Obstructive Pulmonary DiseasePeter Calverley, Ben Vlies
Respirology (Carlton, Vic.)|November 28, 2015
A rational approach to single, dual and triple therapy in COPDPeter Calverley, Ben Vlies
Lancet (London, England)|June 17, 2008
A PEACE-ful solution to COPD exacerbations?Paul Albert, Peter Calverley
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Plugging the gap-understanding mucus plugs in COPDPeter Calverley, Jadwiga A Wedzicha
Drug Safety|December 16, 2020
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A ReviewPeter Calverley, Paola Rogliani, Alberto Papi
British Journal of Clinical Pharmacology|May 21, 2016
Tiotropium safety in 'real-world' populations: Response to Schmiedl, et al. in the British Journal of Clinical PharmacologyRobert Wise, Antonio Anzueto, Ronald Dahl, et al.
COPD|August 31, 2007
Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodologyTerence Seemungal, Robert Stockley, Peter Calverley, et al.
Pageof 6